European Synthetic Biology Market Trends, Growth, Industry Analysis, Size, Share and Forecast 2025

The European synthetic biology market is anticipated to grow at the CAGR of 31.8% during the forecast period. Major European economies contributing in the market are the UK, Germany and France. Various biotech companies are working in the field of synthetic biology in these economies. Additionally, several associations have been established in the region for providing better environment in research and development. Number of universities such as the Cambridge University, have also involved in various studies and research in the field of synthetic biology in collaborations of government or companies or both. Due to this, factor a positive environment for the research and development in synthetic biology has been created in the region.

Get Sample Copy of European Synthetic Biology Market at: https://www.omrglobal.com/request-sample/european-synthetic-biology-market

Some of the players operating in the market include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, Ginkgo Bioworks, and many others.

Furthermore, technological advancements in the life science sector have resulted in increased speed and reduced cost of DNA amalgamation. This enables researchers to design and integrate adjusted bacterial chromosomes that can be utilized as a part of the generation of cutting-edge biofuels, bio-items, sustainable chemicals, and others. The advancements in modern engineering have enabled scientists to build new sequences of DNA.

The European synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling product, core product, and enabled product. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and xeno nucleic acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical application, industrial application, food & agriculture, and environmental applications.

For More Information, get A full report of European Synthetic Biology Market is available at: https://www.omrglobal.com/industry-reports/european-synthetic-biology-market

The report study of the European synthetic biology industry includes the competitive analysis of various players as well as the trend followed by them to sustain in the market. These players are focusing on agreements along with new product launches for expanding their business. For instance, in 2017, Ginkgo Bioworks completed its acquisition of Gen9, a Cambridge based gene synthesis company. With this acquisition, the company aimed at strengthening its market reach in different geographies.

Market Segmentation

Synthetic Biology Market by Product

o Enabling Product
o Core Product
o Enabled Product

Synthetic Biology Market by Technology

o Gene Synthesis & Sequencing
o Genome Engineering
o Bioinformatics
o Others

Synthetic Biology Market by Application

o Medical Application
o Industrial Application
o Food & Agriculture
o Environmental Application

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/european-synthetic-biology-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.